
Please try another search
Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. It offers SPLITTERA technology an innovative, universal and robust solution for site-specific conjugation of proteins. Biotechnology Assets, S.A. is based in Cádiz, Spain.
Name | Age | Since | Title |
---|---|---|---|
Roberto Ramón González de Betolaza García | - | - | Director |
Javier Huergo Luz | - | 2021 | Director |
Jaime Feced Rubio | - | 2020 | President, CEO & Chairman of the Board |
Jerónimo Herrero Manso | - | 2019 | Director |
Andrés Seco García | 54 | - | Director |
John Dixon | - | - | Director |
Victor Manuel Infante Viñolo | - | - | Business Development Director & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review